Product NDC: | 0186-1088 |
Proprietary Name: | TOPROL |
Non Proprietary Name: | Metoprolol succinate |
Active Ingredient(s): | 25 mg/1 & nbsp; Metoprolol succinate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0186-1088 |
Labeler Name: | AstraZeneca LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019962 |
Marketing Category: | NDA |
Start Marketing Date: | 20010326 |
Package NDC: | 0186-1088-39 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0186-1088-39) |
NDC Code | 0186-1088-39 |
Proprietary Name | TOPROL |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0186-1088-39) |
Product NDC | 0186-1088 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Metoprolol succinate |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20010326 |
Marketing Category Name | NDA |
Labeler Name | AstraZeneca LP |
Substance Name | METOPROLOL SUCCINATE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |